This study evaluates the immunohistochemical expression of P16, CD44, estrogen receptor (ER), and progesterone receptor (PR) in CIN and IPM, focusing on their prognostic significance in IPM-to-CIN progression. This evidence concerns the gene ESR1 and cervical squamous intraepithelial neoplasia.